CER Studies and Outcome/Registry Studies

The need for Real World Evidence (RWE) is increasingly important, for both regulatory and commercialisation purposes. Micron has a unique technological base and considerable expertise in delivering CER, Outcomes and Registry studies.

The data generated in these studies contribute towards:
Maximising the impact of investment
Providing essential marketplace support
Delivering outcomes research and economic modelling
Assessing needs and outcomes at healthcare, physician and patient level and measuring behavioural change
Generating modelling systems for cost and burden of illness

Micron has developed OPTImize (Observe, Perform, Train, Improve), a multi-faceted approach for delivering measurable quality improvement for healthcare systems and individual healthcare professionals.